https://orcid.org/0000-0002-5444-8076
References
- Miano M. How I manage Evans Syndrome and AIHA cases in children. Br J Haematol. 2016;172(4):524–534. doi:10.1111/bjh.13866.
- Berrueco R, Dapena JL, Sebastián E, Sastre A. [Controversies in the treatment of paediatric immune thrombocytopenia]. An Pediatr (Barc). 2018;89(3):189.e1-189–e8. doi:10.1016/j.anpede.2018.06.004.
- Guerra F, L'Imperio V, Bonanomi S, et al. Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity. Front Pediatr. 2022;10:1031687. doi:10.3389/fped.2022.1031687.
- Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. Int J Hematol. 2017;105(4):536–539. doi:10.1007/s12185-016-2129-5.
- Cummer E, Donaldson B, Marlowe E, et al. Autoimmune myelofibrosis as a presenting feature of childhood-onset systemic lupus erythematosus: a case report with review of pediatric literature. J Clin Rheumatol. 2021;27(8S):S378–S381. doi:10.1097/RHU.0000000000001533.
- Chalayer E, Ffrench M, Cathébras P. Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review. Springerplus. 2014;3(1):349. doi:10.1186/2193-1801-3-349.
- Kim C, Cheon M, Kang M, Chang I. A simple and exact Laplacian clustering of complex networking phenomena: application to gene expression profiles. Proc Natl Acad Sci U S A. 2008;105(11):4083–4087. doi:10.1073/pnas.0708598105.